首页> 外文OA文献 >Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis

【2h】

Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis

机译：用Nivolumab或Pembrolizumab治疗的晚期胃癌患者免疫相关不良事件的预后：多中心回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
TAKAYUKI ANDO; AKIRA UEDA; KOHEI OGAWA; IORI MOTOO; SHINYA KAJIURA; TAKAHIKO NAKAJIMA; KATSUHISA HIRANO; TOMOYUKI OKUMURA; KENICHIRO TSUKADA; TAKUO HARA; NOBUHIRO SUZUKI; NAOKATSU NAKADA; NAOKI HORIKAWA; TSUTOMU FUJII; ICHIRO YASUDA;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis [J] . Ksienski Doran, Wai Elaine S., Croteau Nicole, Clinical lung cancer . 2019,第1期

机译：Nivolumab和Pembrolizumab在患有治疗中断的患者患者中的疗效因不良事件而需要治疗中断：回顾性多中心分析
2. Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab [J] . Ken Masuda, Hirokazu Shoji, Kengo Nagashima, BMC Cancer . 2019,第1期

机译：纳武单抗治疗胃癌患者免疫相关不良事件与预后的相关性
3. Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study [J] . Okada Naoto, Kawazoe Hitoshi, Takechi Kenshi, Clinical therapeutics . 2019,第1期

机译：用Nivolumab治疗的黑色素瘤患者免疫相关不良事件与临床疗效的关联：多中心回顾性研究
4. Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients [C] . Lorenzen Sylvie, Blank Susanne, Ott Katja St. Gallen EORTC Gastrointestinal Cancer Conference . 2012

机译：在410个新辅助治疗胃癌患者中仅包括Prethereic参数的分数预测响应和预后预测
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis [O] . TAKAYUKI ANDO, AKIRA UEDA, KOHEI OGAWA, 2021

机译：用Nivolumab或Pembrolizumab治疗的晚期胃癌患者免疫相关不良事件的预后：多中心回顾性分析
7. Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study [O] . Saeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto, 2021

机译：绝对淋巴细胞计数预测用Nivolumab单药治疗的非小细胞肺癌患者免疫相关不良事件：多中心回顾性研究

Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅